Resources to Track Your Progress

Measuring treatment success

For pediatric growth hormone deficiency (PGHD), Nutropin AQ® [somatropin (rDNA origin) injection] is prescribed until you stop growing or as determined by your doctor. Your doctor determines when growth hormone therapy should end. At that time, tests will indicate whether or not the growth hormone (GH) may be needed in adulthood. Because GH plays a role in keeping the body healthy, you may need to keep taking Nutropin.

For other indications for Nutropin in children (short stature due to Turner syndrome or idiopathic short stature), Nutropin is given until the child has stopped growing or the family and physician are satisfied with their growth. For children with growth failure associated with CKD, Nutropin is stopped at the time of kidney transplant or earlier, subject to your healthcare team’s medical judgment.

The best way to track your progress with Nutropin is to see how much you are growing. Your doctor has your official growth chart in their medical records. Continue to follow your healthcare provider's instructions regarding your therapy. Individual results may vary.

For adults on Nutropin therapy, success may be gauged using measures such as assessments of body fat and muscle mass, spine bone mineral density and ratio of low-density lipoprotein (LDL) cholesterol to high-density lipoprotein (HDL) cholesterol.

Your doctor is your first source of information. Discuss the potential benefits and risks of GH therapy with your doctor so you are familiar with possible side effects. Be sure to discuss any medications you or your child may be taking.